3-Bromopyruvate is known for glycolytic inhibitors. Potential target is hexoknase II and/or glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
|Catalog #||Material Name||Company Name||Solute/Solvent|
In vitro test:
Dissolve in distilled water to make a 0.5 M stock solution. Aliquote and store at -20 degree
1. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells. Science. 2009; 325:1555. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, Schmidt K, Wilson JK, Markowitz S, Zhou S, Diaz LA Jr, Velculescu V, Lengauer C, Kinzler KW, Vogelstein B, Papadopoulos N.
|MyGenostics, Your Exome|
|GenCapTM technology captures both strands of the Exome with superior evenness for reduced sequencing costs.|
|NucleoBond Xtra Midi/Maxi/EF|
|The new generation of anion exchanger - ultra-fast, transfection-grade plasmid DNA with high yield. Request a sample|
|Eppendorf epMotion 5070|
|A perfect match for all liquid handling applications, such as serial dilutions, reagent distribution PCR/qPCR and sequencing setup.|